Gyre Therapeutics (GYRE) Net Margin Growth (5y) (2015 - 2026)
Gyre Therapeutics (GYRE) Net Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 172,035.00 |
| Mar 31, 2026 | 149,092.00 |
| Dec 31, 2025 | 92,629.00 |
| Sep 30, 2025 | 180,722.00 |
| Jun 30, 2025 | 104,194.00 |
| Mar 31, 2025 | 3,700.00 |
| Mar 31, 2023 | 8.40 Mn |
| Dec 31, 2022 | 177,965.00 |
| Mar 31, 2022 | -30,379.00 |
| Dec 31, 2021 | 440,771.00 |
| Sep 30, 2021 | 327,928.00 |
| Jun 30, 2021 | 267,352.00 |
| Mar 31, 2021 | 176,590.00 |
| Dec 31, 2020 | 503,880.00 |
| Sep 30, 2020 | 161,010.00 |
| Jun 30, 2020 | -53,552.00 |
| Mar 31, 2020 | 98,000.00 |
| Mar 31, 2018 | -8.38 Mn |
| Dec 31, 2017 | 90,800.00 |
| Sep 30, 2017 | -79,579.00 |